Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I1TM
|
|||
| Former ID |
DIB012371
|
|||
| Drug Name |
FP-1102
|
|||
| Synonyms |
Farbetics; FP-1101; AOC3 protein inhibitors (incipient vasculopathies), Faron Pharmaceuticals; Vascular adhesion protein 1 inhibitor (incipient vasculopathies), Faron Pharmaceuticals; Vitamin B1 analog (incipient vasculopathies), Faron Pharmaceuticals
Click to Show/Hide
|
|||
| Indication | Vascular disease [ICD-11: BE2Z; ICD-9: 325, 430-459] | Investigative | [1] | |
| Company |
Faron Pharmaceuticals Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Membrane copper amine oxidase (AOC3) | Target Info | Inhibitor | [1] |
| BioCyc | Phenylethylamine degradation I | |||
| Spermine and spermidine degradation I | ||||
| KEGG Pathway | Glycine, serine and threonine metabolism | |||
| Tyrosine metabolism | ||||
| Phenylalanine metabolism | ||||
| beta-Alanine metabolism | ||||
| Metabolic pathways | ||||
| Panther Pathway | Phenylethylamine degradation | |||
| Pathwhiz Pathway | Beta-Alanine Metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2767). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.